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As clinical toxoplasmosis is not considered a problem in pigs, the main reason to implement a control strategy against
Toxoplasma gondii (T. gondii) in this species is to reduce the establishment of T. gondii tissue cysts in pork, consequently
reducing the risk of the parasite entering the human food chain. Consumption of T. gondii tissue cysts from raw or
undercooked meat is one of the main sources of human infection, with infected pork being considered a high risk. This
study incorporates a mouse bioassay with molecular detection of T. gondii DNA to study the effectiveness of vaccination
(incomplete S48 strain) in its ability to reduce tissue cyst burden in pigs, following oocyst (M4 strain) challenge. Results
from the mouse bioassay show that 100% of mice which had received porcine tissues from vaccinated and challenged
pigs survived compared with 51.1% of mice which received tissues from non-vaccinated and challenged pigs. The
presence (or absence) of T. gondii DNA from individual mouse brains also confirmed these results. This indicates a
reduction in viable T. gondii tissue cysts within tissues from pigs which have been previously vaccinated with the S48
strain. In addition, the study demonstrated that the main predilection sites for the parasite were found to be brain and
highly vascular muscles (such as tongue, diaphragm, heart and masseter) of pigs, while meat cuts used as human food
such as chop, loin, left tricep and left semitendinosus, had a lower burden of T. gondii tissue cysts. These promising
results highlight the potential of S48 strain tachyzoites for reducing the number of T. gondii tissues cysts in pork and thus
improving food safety.Introduction
The protozoan parasite Toxoplasma gondii (T. gondii) has
the ability to infect all warm blooded mammals, including
humans and livestock. Livestock are known intermediate
hosts of T. gondii. Food animals such as pigs, sheep, goats
and cattle become infected with the parasite, either from
consumption of oocysts shed in the environment by the
definitive host (felids), or in the case of pigs, from consum-
ing other infected intermediate hosts such as rodents [1].
Following T. gondii infection, cysts form in the tissues of
the animal (tissue cysts), these cysts contain the bradyzoite
stage of the parasite and can survive for the lifetime of the
host. The ability of tissue cysts to establish within food pro-
ducing animals varies; cattle rarely have detectable tissue* Correspondence: frank.katzer@moredun.ac.uk
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unless otherwise stated.cysts, even in animals which have been experimentally
challenged [2,3], whilst in sheep, pigs and goats, tissue cysts
are more commonly identified [4]. Tissue cysts have a pref-
erence to establish in specific tissues of the host, such as
liver, heart, brain, tongue, diaphragm, and skeletal muscle
[5,6]. Viable parasites and tissue cysts have also been iso-
lated from cuts of meat and meat products destined for
human consumption from naturally and experimentally in-
fected animals [7-11]. Consumption of raw or under-
cooked meat from animals containing tissue cysts is a
main source of T. gondii infection in humans, with infected
pork considered to be the major source of infection
[12,13].
Outdoor reared pigs are more likely to become in-
fected with the parasite compared with those reared in-
doors [14,15], with the main source of infection thought
to be from consumption of oocyst contaminated feed,
water and/or soil [16]. In addition, outdoor housing. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Animal groupings for vaccination and T. gondii
challenge
Group Vaccination and/or challenge Number of
animals
Day 0 Day 28
1 n/a 1000 M4
oocysts
5
2 1.2 × 105 S48
tachyzoites
1000 M4
oocysts
5
3 1.2 × 105 S48
tachyzoites
n/a 5
4 n/a n/a 3
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dents and other wildlife species. Due to their omnivor-
ous nature pigs will consume rodents or rodent cadavers
as well as other small mammals and birds, which may be
infected with T. gondii and several studies have demon-
strated how rodent control programs can reduce T. gon-
dii seropositivity in pigs [1,17].
Although clinical toxoplasmosis in pigs is rare, and
certainly not a common enough problem to warrant the
commercial use of a vaccine against the parasite, the for-
mation of tissue cysts in the muscles of infected animals
can pose a significant risk for food safety and is thought
to be one of the most important sources of T. gondii in-
fection for humans, particularly when pork is eaten
undercooked or raw [18,19].
A vaccine which can reduce or eliminate the formation
of infective tissues cysts in pigs would be beneficial for
pork products intended for human consumption, reducing
the potential public health risk from T. gondii infection.
Previous research into the reduction of the formation of
tissue cysts in pigs has included work using live and killed
vaccine approaches [20-25]. It is currently unknown
whether the commercially available vaccine Toxovax®
(comprised of the S48 strain of T. gondii and used to pro-
tect against ovine abortion caused by the parasite), offers
any protection against tissue cyst formation in livestock
species. This lack of knowledge regarding the ability of S48
to protect against tissue cyst formation was highlighted, as
a key knowledge gap, in a recent document produced for
the Food Standards Agency [26]. The document stated that
one of the gaps in the current knowledge relevant to a UK
risk assessment was: “Vaccines based on live attenuated
strains of tachyzoites are effective in reducing morbidity in
sheep but it is not known whether vaccination has any effect
on the formation of tissue cysts”. Therefore, to address this
knowledge gap and potentially improve food safety, this
study focused on the effect of vaccination of pigs with the
S48 strain of T. gondii in order to reduce tissue cyst for-
mation. The S48 strain was originally isolated from a case
of ovine abortion in New Zealand, which after approxi-
mately 3000 passages in mice lost its ability to develop
into tissue cysts (bradyzoites) in mice and oocysts in cats
[27,28].
The objective of this research was to evaluate the effect-
iveness of this live attenuated strain of T. gondii (S48) in
its ability to reduce viable tissue cysts within porcine tis-
sues. A reduction, or indeed elimination, of viable tissue
cysts in pork would make this food source safer for hu-
man consumption. In addition, another objective was to
ensure that the S48 strain used for vaccination did not
persist in the pig tissues. Finally, the research aimed to
provide an insight into the predilection sites for the para-
site within specific porcine tissues, including tissues used
within the human food chain.Materials and methods
Pig vaccination and challenge
A total of 18 pigs, six week old Large White/Landrace
cross bred pigs (Sus scrofa) of mixed gender, were di-
vided into four groups (G) depending on experimental
challenge; G1 (n = 5) non-vaccinated and oocyst chal-
lenged animals, G2 (n = 5) vaccinated and oocyst chal-
lenged animals, G3 (n = 5) vaccinated non-challenged
animals, G4 (n = 3) non-vaccinated and non-challenged
animals. The five animals in G2 and G3 were vaccinated
subcutaneously (SC) with 1.2 × 105 S48 tachyzoites
4 weeks prior to experimental challenge (day 0) (see
Table 1). Four weeks following vaccination (day 28) ani-
mals in G1 and G2 were orally challenged with 103 T.
gondii oocysts of the M4 strain. During the experiment
all animals were fed using a commercial pig feed and
water was available ad libitum. All animal procedures
complied with the Animals (Scientific Procedures) Act
1986 and were approved by the Moredun Research Insti-
tute ethics committee.Sampling and measurements
Rectal temperatures of all pigs were monitored daily for
14 days post vaccination. At day 28 all animals were
micro-chipped, iDENTICHIP® with Bio-Thermo (Animal-
care Ltd., York, UK), and temperature monitored for
14 days post challenge. Blood sampling was carried out
weekly from days 0 to 70 of the experiment. Blood was col-
lected from the anterior vena cava using a 2.7 mL S-
monovette serum tube with an S-monovette 20G × 1.5”
safety needle (Sarstedt, Leicester, UK). Blood was left to
clot overnight at 4 °C, tubes centrifuged for 10 min at
2000 g and serum transferred to a sterile 1.5 mL tube.
Serum samples were stored at −20 °C until required. All 18
pigs were euthanised six weeks post challenge (day 70 of
the experiment), by electrical stunning followed by sever-
ing of the jugular vein and exsanguination. Tissues (brain,
chop, loin, left tricep, left semitedinosus, heart, masseter,
tongue and diaphragm) were collected at post mortem for
DNA extraction, pathology and mouse bioassay.
Burrells et al. Veterinary Research  (2015) 46:47 Page 3 of 12Mouse bioassay
Mouse bioassay is considered the gold standard for de-
termining the viability of T. gondii tissue cysts [29].
Ninety Porton mice (a minimally inbred stain), were
used for the mouse bioassay. Food and water was sup-
plied ad libitum and animals clinically monitored twice
daily. Tissues from pigs in G1 (unvaccinated and oocyst
challenged) and G2 (vaccinated and oocyst challenged
pigs) were used for the mouse bioassay. Tissues were
separated into three different 50 g groups, each group
was based on the tissue type and divided into the follow-
ing; “Brain” (50 g of brain), “Food” (a 50 g pooled sample
which included 12.5 g each of chop, loin, left tricep and
left semitendinosus), and “Other” (a 50 g pooled sample
which included 12.5 g each of diaphragm, heart, tongue
and masseter). These tissues were digested with acid/pep-
sin using a method previously described [30]. The tissue
homogenate was centrifuged for 10 min at 1200 g, the
supernatant was poured off gently and the final pellet was
resuspended in 3 mL sterile saline (which contained
400 μg/mL penicillin and 400 units/mL streptomycin).
Three mice were intraperitoneally injected with 400 μL of
each inocula. An additional 400 μL of the inocula was
stored at −20 °C for subsequent DNA extraction.
Tissues from pigs in G3 (vaccinated and non-challenged)
and G4 (negative control group animals) were not included
in the mouse bioassay.
Mice that showed either signs of infection, or which
survived until the end of the six week bioassay, were
euthanised by cervical dislocation. Blood samples were
taken and brain tissue collected from each mouse. Half
of each brain was stored separately in a sterile vial
containing 1 mL PBS for DNA extraction, whist the
remaining half was placed in 1 mL 10% buffered forma-
lin for pathological examination.
Detection of T. gondii DNA from mouse brains following
bioassay
DNA extraction followed by a T. gondii specific nested
ITS1 PCR (n-PCR) was completed for all mice used in
the bioassay (n = 90). DNA extraction (adapted from
[31]) initially required the homogenisation of each brain
sample, which was achieved by passing the material
through an increasing gradient of fine gauge needles
(18G, 21G and 25G needles). 900 μL of Nuclei Lysis So-
lution (Promega, UK). Each 400 μL of mouse brain hom-
ogenate was incubated overnight at 55 °C, then once
cooled, 300 μL of Protein Precipitation Solution (Pro-
mega) was added, mixed and incubated on ice for 5 min.
The mixture was then centrifuged at 13 000 g for 5 min
and the resulting supernatant transferred to a 2 mL tube
containing 900 μL of isopropanol. Each tube was mixed
by inversion and incubated at −20 °C overnight. The
DNA was pelleted by centrifugation at 13 000 g for5 min, supernatant removed and DNA pellet washed
with 600 μL 70% ethanol. To avoid contamination, a
DNA extraction control was included within each batch
of extractions. The DNA pellet was centrifuged a second
time and any residual ethanol removed and the pellet
briefly air dried, with final re-suspension in 200 μL ster-
ile H2O. To identify the presence of T. gondii DNA, a T.
gondii specific ITS1 PCR was used, as previously de-
scribed [32]. The ITS1 PCR was completed in triplicate
for each mouse brain DNA sample. A positive control
(T. gondii RH DNA) and multiple negative controls as
well as the DNA extraction control were included within
each PCR run.
Detection of T. gondii DNA from mouse bioassay inocula
DNA was extracted from a 400 μL aliquot of the acid/
pepsin porcine tissue homogenate (as previously de-
scribed within this paper for DNA extraction from
homogenised mouse brains). The DNA generated was
tested for the presence of T. gondii by two different mo-
lecular methods; a qPCR targeting the T. gondii 529 bp
repeat element [10], and the T. gondii ITS1 n-PCR [32]
which is described throughout this study. By using both
of these methodologies, the molecular detection of the
parasite can be compared between the different tech-
niques. In addition, this also allows the results from the
molecular detection of the parasite, using DNA from the
inocula, to be compared to detection of the parasite within
individual mouse brains from the bioassay (mouse bio-
assay vs. molecular detection from bioassay inocula).
Molecular detection of T. gondii DNA from pig tissues
DNA was extracted and tested for the presence of T.
gondii from the following porcine tissues: brain, chop,
loin, left tricep, left semitendinosus, diaphragm, heart,
tongue and masseter. Aliquots of 1 g of each tissue for
all pigs (n = 18) were tested individually. DNA was ex-
tracted using Precellys tubes containing ceramic beads
(Peqlab, UK), followed by the T. gondii n-ITS1 specific
PCR (used to detect T. gondii DNA), using the method-
ology previously described [31,32]. Each PCR was car-
ried out in triplicate, with a positive control (T. gondii
RH DNA), multiple negative controls and DNA extrac-
tion controls included within each PCR run.
Porcine T. gondii IgG enzyme linked immunosorbent
assay (ELISA)
The porcine T. gondii IgG ELISA was adapted from a
similar methodology described for detection of T. gondii
IgG in sheep [33]. Flat-bottom 96 well polystyrene micro-
titration plates (MICROLON, 96K, F-form, medium bind-
ing, Greiner Bio-one, Germany) were coated with 0.1 mL
(2.5 μg/mL) of T. gondii tachyzoite antigens prepared as
previously described [34], diluted in 0.1 M carbonate
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plates were washed 3 times with PBS-Tween 20 (0.07 M
PBS/ 0.05% Tween 20 (PBS-T)) and non-specific immune
sites blocked by incubation for 1 h at 37 °C with 125 μL of
PBS-1% bovine serum albumin (BSA). Control and test
sera were diluted 1:100 in PBS-T-1% BSA and added to
the microtitre plates in duplicate, 0.1 mL in each well, and
incubated for 1 h at 37 °C. Positive and negative control
sera (pool of three animals) were included in each plate.
After washing, peroxidase-labeled anti-pig IgG antibody
(Sigma A5670, diluted 1:10 000 in PBS-T-1% BSA) was
added 0.1 mL in each well and incubated for 1 h at 37 °C.
After washing, the peroxidase activity was revealed by
adding 0.1 mL of substrate solution (SureBlue TMB
Microwell Peroxidase Substrate, KPL, Gaithersburg, MD,
USA), and the reaction was stopped by adding 0.1 mL of
2 M H2SO4, and the optical density (OD) was read at
450 nm in an ELISA microplate reader (MRXII, thermo
Labsystems). The average OD-value for the blank controls
on a plate was subtracted from the OD-values of the sera
on each plate. For control of plate-to-plate variation, the
same positive and negative control sera were included on
every plate and a corrected OD value was calculated for
each sample as described previously [35]. A serum sample
was considered to be positive when OD-value of the
serum sample is greater than OD mean (from negative
sera obtained from all plates, n = 64 – negative sera from
the current experiment) plus 2 standard deviation (SD
from negative serum from all plates).
Quantification of histopathological lesions and
imunohistochemistry labelling of porcine tissues
Methodology was carried out as described by [11].
Briefly, during histopathological examination, the num-
bers of glial foci and perivascular cuffs were counted for
each tissue. IHC labelled slides were examined for la-
belled T. gondii-like structures (tachyzoites and tissue
cysts). An animal was considered positive by IHC when
positive labelling of tissue cysts or tachyzoites were
found in at least one of its tissue sections.
Murine T. gondii IgG ELISA
The ID Screen Toxoplasmosis Indirect Multi-species
ELISA kit (ID.vet, Montpellier, France) was used to de-
tect IgG against T. gondii from mouse serum. The sup-
plied manufacturer’s instructions were followed and
plates were read at 450 nm using the same ELISA reader
as previously described. An ELISA was valid if the mean
value of the positive control OD (ODpc) was greater than
0.035 (ODpc > 0.035), and if the ratio of the mean OD
values for the positive and negative controls (ODpc and
ODnc), were greater than 3.5 (ODpc/ODnc > 3.5).
The interpretation of the result was classed as percent
seropositivity (SP). A sample with an SP value of 50% orhigher was positive, a negative result was an SP of 40%
or less, and the result classed as doubtful if the SP was
between 40% - 50%.
Statistical analysis
To account for the increased variability with the mean,
the weekly data on OD-value obtained from ELISA of
serum samples of pigs post-vaccination were transformed
using square root transformation. A repeated measures
model was fitted to the transformed data incorporating
treatment group, time (week post-vaccination as a cat-
egorical variable) and interaction between treatment
group and time as fixed effects. The model considered a
first-order autoregressive correlation structure between
observations for each pig. The data on weekly rectal
temperature of pigs were also analysed using a similar re-
peated measures model. Possible biologically interesting
comparisons of differences in mean values between treat-
ment groups were obtained using two-sided probabilities
for each comparison. These probabilities were then ad-
justed using a False Discovery Rate (FDR) approach [36]
to take into account the multiple comparisons of means
so that the overall FDR was less than 5%. All p-values in
this paper refer to FDR-adjusted probabilities unless they
are specified to be global p-values.
For the mouse bioassay, all 45 mice, that received tis-
sues (15 mice each fed with brain, food and other tis-
sues) from the pigs of the G2 group (vaccinated and
oocyst challenged), survived until the end of the experi-
ment (day 42), and therefore, all data in this group were
censored. A total of 22 mice, inoculated with tissues
from the pigs of the G1 group (unvaccinated and oocyst
challenged), died at different intervals. A Kaplan-Meir
survival curve was plotted to present the mean survival
proportions of mice between the two groups and the
equality between two survival curves was tested using
G-rho family of test [37]. Similarly, the equality of sur-
vival distributions between a pair of tissues within G1
group was also tested considering pig as a stratum vari-
able. To account for multiple comparisons, these prob-
abilities were then adjusted using a False Discovery Rate
(FDR) approach as discussed earlier.
To test the agreement of each of the two molecular
tests used for detection of parasite DNA from bioassay
inocula (T. gondii 529 bp qPCR and conventional PCR
incorporating the T. gondii specific ITS1 region) with
gold standard test (the detection of T. gondii DNA dir-
ectly from mouse brains following bioassay), the data on
discordant cells were tested using an exact test of a null
hypothesis about the equal probability of success (p =
0.5) in a Bernoulli distribution. Additionally, the data
from the contingency table were used to estimate the
sensitivity and specificity of both molecular tests and
corresponding exact binomial confidence intervals.
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ware version 3.0.1 with appropriate R packages (stats,
nlme, multcomp, survival, ggplot) [38].
Results
Clinical observations in pigs
Rectal temperatures of all animals were recorded from
days −5 to 14 of the experiment. Estimates of mean rectal
temperature and 95% confidence intervals for four treat-
ment groups along with observed temperature on each in-
dividual pig at each day post-vaccination (until day 14) are
presented in Figure 1, although this can be noted in ab-
sence of oocyst challenge (which occurred on day 28), G1
& G4 and G2 & G3 are identical. Due to the increasing
size of the animals, the technique used for recording the
temperature from days 28 – 42 (daily for 14 days following
oocyst challenge) was an implanted Thermochip®. How-
ever, this technique did provide accurate recording of the
rectal temperature, probably due to the location of the
chip. Temperatures fluctuated greatly resulting in vast var-
iations of temperature readings. These readings were notFigure 1 Average porcine temperature per experimental group follow
pig was recorded daily prior to challenge. Between days 0 – 14 post vaccinat
cut off line indicates the normal rectal temperature for pigs. G1 = Oocyst (M4)
G3 = Vaccinated (S48) pigs, G4 = Negative control pigs.reliable or informative, and therefore, were not used for
further statistical analysis. On day 7 post-challenge (i.e. on
day 35 of the experiment), all five animals in G2 appeared
subdued/depressed for approximately 24 h, although they
remained interested in food and movement was un-
affected. All other animals remained clinically normal
throughout the experiment.
Molecular detection of T. gondii from individual pig
tissues
DNA extracted from individual tissues (brain, chop, loin,
left tricep, left semitendinosus, diaphragm, heart, tongue
and masseter) from all pigs in G1, G2, G3 and G4 was
tested for the presence of T. gondii DNA using the ITS1
n-PCR. Parasite DNA was not detected from any of
these tissues, despite each DNA sample being tested in
triplicate.
Porcine T. gondii IgG ELISA
Estimates of the mean transformed OD values (square
root transformation) and corresponding 95% confidenceing vaccination with S48 tachyzoites. Rectal temperatures of each
ion, treatment groups G1 and G4, and G2 and G3 are identical. The red
challenged pigs, G2 = Vaccinated (S48) and oocyst (M4) challenged pigs,
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OD values on each individual pig at each week post-
vaccination are presented in Figure 2. Briefly, all pigs
tested negative by ELISA for T. gondii IgG at the begin-
ning of the experiment (day 0 post-vaccination), however,
by day 42 post-vaccination (or 2 weeks after challenge
with T. gondii oocysts for G1 and G2), most of the pigs
(apart from the pigs in G4 – negative control animals)
were T. gondii IgG positive (OD-value greater or equal to
0.34, or equivalently, square root of OD-value greater or
equal to 0.58; see Figure 2). The interaction effect of treat-
ment group and time had a statistically significant (global
p < 0.001) effect on the mean OD. The results showed that
the mean OD value of pigs from G2 (pigs which were vac-
cinated with S48 and then challenged four weeks later
with 103 M4T. gondii oocysts) were statistically signifi-
cantly higher compared with G3 animals (pigs which were
vaccinated and not challenged) at day 49 (p = 0.019), 63
(p < 0.001) and 70 (p = 0.017) post-vaccination (Figure 2).
Mean OD values were higher in magnitude for the G2Figure 2 T. gondii IgG ELISA. T. gondii IgG ELISA results for all pigs from w
each pig (small dots), estimated mean ELISA value of each group (large solid
(shaded region). The vertical dashed line indicates the point at which pigs we
indicates when animals were classed as seropositive for T. gondii.G1 = Oocyst
pigs, G3 = Vaccinated (S48) pigs, G4 = Negative control pigs.group compared with G3 on day 42 and 70, but the mean
differences were not statistically significant (p > 0.05). The
negative control animals (G4) remained seronegative
throughout the experiment as OD values were below the
threshold during the entire experimental period (see
Figure 2).
Quantification of histopathological lesions and
immunohistochemistry labelling of porcine tissues
Histological examination of the brain from the infected
pigs showed mild non purulent perivascular infiltration,
randomly distributed, in four animals from G1 and one
animal from G2, mainly formed by CD3 positive lym-
phocytes. Besides these lesions, mild, focal, non-specific
infiltration of few mononuclear inflammatory cells,
mainly lymphocytes in the lungs and the different mus-
cles studied were found in the all the animals studied.
No differences were found between the studied groups
regarding these non specific changes. Immunohisto-
chemical labelling showed few intracellular T. gondiieek 0 to 70 post vaccination. Plots show observed ELISA value of
dots joined by solid line) and corresponding 95% confidence intervals
re challenged with 1000 M4 T. gondii oocysts. The horizontal dashed line
(M4) challenged pigs, G2 = Vaccinated (S48) and oocyst (M4) challenged
Figure 3 Kaplan-Meir survival curves. Kaplan-Meir survival curve
in relation to vaccination highlighting proportion of mice that
survived when fed tissues from G1 and G2 pigs (A). All mice which
received tissues from vaccinated and challenged pigs (G2) survived
(blue line) until the end of the bioassay (day 42). Only 51.1% of mice
which received tissues from unvaccinated and challenged pigs (G1)
survived until the end of the bioassay (day 42). G1 =Mice inoculated
with porcine tissues from pigs which were vaccinated (S48) and
oocyst (M4) challenged. G2 = Mice which were inoculated with
porcine tissues from pigs which were oocyst (M4) challenge. Kaplan-
Meir survival curve from mice fed different tissues from pigs in G1
highlighting proportion of mice that survived when fed different
tissue types (brain, food and other) (B). Brain = brain tissue, Food =
pooled sample of chop, loin, left tricep and left semitendinosus,
Other = pooled sample of diaphragm, heart, tongue and masseter.
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from one animal from G1 and in the retromandibular
lymph node of another animal from G2.
Mouse bioassay
During the 6 week mouse bioassay 75.6% (68/90) of
mice survived until the end of the experiment. Twenty
two of 90 mice (24.4%) had to be euthanised due to the
manifestations of clinical signs of T. gondii infection
(ruffled coat, reluctance to move). All of these mice had
received tissues from G1 pigs (unvaccinated and chal-
lenged with M4 T. gondii oocysts). From G1 mice, four
animals were euthanised on day 11 of the experiment,
and a further18 mice were euthanised on day 12, which
left a total of 51.1% (23/45) of mice surviving until the
end of the experiment (day 42) (see Figure 3A). In con-
trast, all mice, which received tissues from G2 pigs (vac-
cinated with S48 and challenged with M4 T. gondii
oocysts), survived to the end of the experiment, resulting
in 100% (45/45) survival of mice (Figure 3A). It was
therefore not surprising that the independent two-
sample log-rank test of the censored survival data until
day 42 of the experiment showed strong evidence (p <
0.001), that mice which received porcine tissues from
G2 pigs had a higher probability of survival across the
entire range of the experimental period compared with
mice which received G1 porcine tissues.
For mice that received tissues from G1 pigs, there was
evidence that the mean proportion of mice that survived,
differed between the porcine tissues (brain, food and
other) that they were inoculated with (Figure 3B).
Among them, 40% (6/15), 26.7% (4/15) and 86.7% (13/
15) of mice survived when they were inoculated with
“brain”, “other” and “food” tissues, respectively. Mice
that received “food” tissues had a statistically signifi-
cantly higher chance of surviving during the entire study
period compared with mice that received “brain” (p =
0.018) and “other” (p < 0.001) tissues. The probability of
survival between the mice that received “brain” and
“other” tissues did not differ significantly (p = 0.340).
Detection of T. gondii DNA from mouse brains following
bioassay
Brains from the 22 mice which were euthanised prior to
the end of the six week mouse bioassay (all fed with G1
pig tissues – as shown in Figure 4), were positive by
ITS1 n-PCR and T. gondii DNA was detected within the
brains of all 22 mice. When DNA was extracted from
the brains of the remaining 66 mice (which did not show
any signs of T. gondii infection and were euthanised on
day 42 of the bioassay), an additional two mice, which
had been inoculated with brain tissue from G1 pigs,
were identified as ITS1 positive. Therefore, T. gondii
DNA was detected in 53.3% (24/45) of mouse brainswhich had been inoculated with tissues from G1 pigs
(see Table 2). In contrast, 100% (45/45) of mice, which
had been inoculated with tissues from G2 pigs, tested
negative for T. gondii by ITS1 PCR (see Table 2).
Detection of T. gondii DNA from bioassay inocula
Homogenised and acid/pepsin digested pig tissues used
as inocula to challenge the mice were tested for the
presence of T. gondii DNA. All inocula (n = 30) were
tested (“food”, “brain” and “other” per pig, giving 15 in-
ocula per experimental group), using both the T. gondii
ITS1 PCR and the T. gondii 529 bp qPCR. T. gondii
DNA could not be detected in any of the inocula (0/15)
generated from G2 pigs by either of conventional T.
Figure 4 Mouse survival rate related to specific porcine tissues (experimental groups G1 and G2). All mice which received homogenised
tissue from G2 pigs survived. Not all mice which received porcine tissues from G1 pigs survived, with only 40% of mice which received brain
tissue surviving, followed by 26.7% which received food and 86.7% receiving other.
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sults from the ITS1 n-PCR showed that 7/15 (46.7%) of
inocula comprised of tissues from pigs in G1 were posi-
tive for T. gondii DNA (Table 4). Of the seven positives,
four were from the inocula containing “brain” tissue,
two from the inocula comprised of the “other” tissues
and one from the inocula comprised of the “food” tissues
(Table 4). However, among inocula generated with tis-
sues from G1 pigs, detection of T. gondii DNA using the
qPCR was slightly lower compared with detection using
the ITS1 n-PCR, with 6/15 (40.0%) of inocula testing
positive by qPCR (compared to 7/15 (46.7%) by ITS1
PCR) (see Table 4). Inocula, which were used for bio-
assay in mice, with subsequent detection of T. gondii
DNA directly from mouse brain, detects the greatest
number of T. gondii positive tissue samples, resulting in
9/15 (60%) of pig tissue inocula testing positive. Four of
these positives were detected in inocula comprised of
“brain”, four from “other” and one from “food” tissues.
Considering the data on bioassay results, there was how-
ever no evidence that mean proportions of detectable in-
fected and non-infected samples differed between tissues
(global p = 0.201).Table 2 Summary of T. gondii DNA detected by ITS1 PCR in m
Mouse Group ITS1 positive mice (n) % ITS1 pos
1 24a 53.3
2 0 0
TOTAL 24 26.7
a = including two mice which survived until the end of the end of the experiment (
1 =mice inoculated with porcine tissues from oocyst challenged pigs.
2 = mice inoculated with porcine tissues from vaccinated and oocyst challenged pigComparison of molecular detection methods for
detection of T. gondii DNA using bioassay inocula
Two molecular tests (T. gondii 529 bp qPCR and the T.
gondii specific n-ITS1 PCR) were compared for their de-
tection of parasite DNA from bioassay inocula using a
gold standard test. The detection of T. gondii DNA dir-
ectly from mouse brains following bioassay was consid-
ered as the “gold standard” as parasite DNA was
detected in 9 out of 15 samples (60%) (see Table 4). The
qPCR detected 6 out of 15 samples (40%), compared
with 7 out of 15 samples (46.7%) by ITS1-PCR. Results
showed that both qPCR (p = 0.250) and ITS1-PCR (p =
0.500) are in agreement with the gold standard test.
However, the estimate of sensitivity of the ITS1 PCR
(0.78 with 95% confidence interval: 0.40, 0.97) was
higher compared with the 529pb qPCR (0.67 with 95%
confidence interval: 0.30, 0.93). The estimates of specifi-
city and 95% confidence interval for both tests were
identical for both methods (1.00; 0.77, 1.00).
Mouse serology and pathology
Serum samples from all mice (n = 90) were collected at
post mortem and tested for the presence T. gondii IgGouse brains following bioassay with porcine tissues
itive ITS1 negative mice (n) % ITS1 negative
21 46.7
45 100
66 73.3
42 dpi).
s.
Table 3 Detection of T. gondii DNA from bioassay inocula
(homogenised tissues) compared to detection of T. gondii
DNA from mouse brain (bioassay) from vaccinated and
oocyst challenged pigs (G2)
Pig No. Brain Other Food
qPCR ITS1 Bio qPCR ITS1 Bio qPCR ITS1 Bio
820 − − − − − − − − −
821 − − − − − − − − −
822 − − − − − − − − −
823 − − − − − − − − −
824 − − − − − − − − −
Positives 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5 0/5
Results from the 529 bp T. gondii qPCR (qPCR), conventional T. gondii ITS1 PCR
(ITS1) and ITS1 PCR from mouse brain – bioassay result (Bio), from vaccinated
and oocyst challenged pigs (G2).
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ELISA. The majority of mice (98.9%, 89/90) tested sero-
negative (with seropositivity (SP) ≤ 3%), which included
all 22 mice euthanised due to signs of T. gondii infec-
tion. One mouse (C11-1), which was inoculated with
brain tissue from a pig G1 pig, tested positive by ITS1
PCR and survived until the end of the experiment (day
42), was classified as seronegative (23% SP). However,
the percentage seropositivity of this mouse was much
higher than that of the remaining 89 seronegative mice.
Only one mouse (C11-2), which was also inoculated with
brain tissue from a pig in G1, tested positive for T. gon-
dii IgG (189% SP, this mouse was euthanised at the end
of the experiment (day 42) and tested positive by ITS1
PCR.
The pathological results completed on half of each
mouse brain (n = 90) could not identify any differences
between mice inoculated with different porcine tissues
(brain, food and other), with the exception of three ani-
mals, where tissue cysts were observed (C11-2, C14-3
and C18-2), which had been inoculated with tissues from
pigs in G1.Table 4 Detection of T. gondii DNA from bioassay inocula
(homogenised tissues) compared to detection of T. gondii
DNA from mouse brain (bioassay) from oocyst challenged
pigs (G1)
Pig No. Brain Other Food
qPCR ITS1 Bio qPCR ITS1 Bio qPCR ITS1 Bio
825 + + + − − − − − −
826 + + + + − + − − −
827 + + + − − + − − −
828 + + + − + + − − −
829 − − − − + + + + +
Positives 4/5 4/5 4/5 1/5 2/5 4/5 1/5 1/5 1/5
Results from the 529 bp T. gondii qPCR (qPCR), conventional T. gondii ITS1 PCR
(ITS1) and ITS1 PCR from mouse brain – bioassay result (Bio), from oocyst
challenged pigs (G1).Discussion
The results from this work clearly show that vaccination
with a live attenuated strain of the parasite (S48) and
subsequent challenge with T. gondii oocysts (M4) in pigs
is successful in significantly reducing infective tissue
cysts from establishing within porcine tissues, as shown
by the mouse bioassay. Mouse survival rates from the
bioassay at day 42 pi show a clear difference between
those mice inoculated with tissues from pigs in G1 (un-
vaccinated and oocyst challenged pigs), compared with
mice inoculated with tissues from pigs in G2 (vaccinated
and oocyst challenged pigs) (Figure 3A). In our experi-
ence, infection with the M4 strain (type II) of T. gondii
is likely to cause clinical signs in Porton mice, where vi-
able tissue cysts present in the inocula (homogenised
porcine tissue), generally results in severe clinical signs
in mice and euthanasia is required. Therefore, in this
study, reporting of mouse survival was important as it
was a good indicator of the presence or absence of viable
tissue cysts. It has previously been reported that as little
as one tissue cyst (containing possibly thousands of in-
fective bradyzoites) is enough to cause infection [39].
Other research, which has studied the vaccination of
pigs to reduce tissue cyst burden, has mainly focused on
microscopic identification of tissue cysts and/or detec-
tion of parasite DNA from mice used in the bioassay
[21,23-25,35,40,41]. In these studies there is no detailed
information about mouse survival and clinical signs of
T. gondii during the bioassay itself. In fact, very few T.
gondii studies, which incorporate mouse bioassays to as-
sess the viability of tissue cysts, describe mouse survival
rates in any detail. However, this might also be related to
the strain of mouse used, as Swiss Webster mice (al-
though susceptible to T. gondii) are generally thought to
be more resistant to the parasite and are less likely to
show clinical signs of infection. Research by Pena et al.
[42], have reported mouse mortality rates following bio-
assay of cat tissues in relation to the genotype of T. gon-
dii present. Our current research describes mouse
survival rates using a Kaplan-Meir survival curve. Mouse
survival provides an indication of the viability of T. gon-
dii tissue cysts, however, this data is lacking in the ma-
jority of studies which incorporate mouse bioassay.
In addition to mouse survival rates, T. gondii DNA
was not detected in any mice (0/45) following challenge
with inocula comprised of porcine tissues from G2 pigs
(vaccinated and oocysts challenged pigs) (Table 3), whilst
parasite DNA was detected in 53.3% (24/45) of mice fol-
lowing challenge with inocula from G1 pigs (non-vacci-
nated oocyst challenged) (Table 4). Other research,
investigating vaccination and T. gondii challenge of pigs
and subsequent mouse bioassay, have focused only on the
microscopic detection of tissues cysts from mouse brain
following bioassay [18,21,25,41], rather than detection of
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pathology results from the current research provide lim-
ited information, it is difficult to draw direct comparisons
between these vaccination and challenge experiments and
the current research. However, as 100% of mice from the
bioassay survived following inoculation with tissues from
pigs vaccinated and oocyst challenge, vaccination with S48
tachyzoites appears to be a very promising approach for
reducing parasite burden in porcine tissues. Previous re-
search into vaccination of pigs against T. gondii, which
have incorporated mouse bioassay, have not shown such a
protective response against tissue cyst formation in mouse
brains. For example, following immunisation of pigs with
crude T. gondii rhoptry proteins with Quil-A as an adju-
vant, da Cunha et al. [41] found only partial protection
from formation of tissue cysts in mouse brains following
bioassay with porcine tissues, with the parasite detected in
5/11 (45.4%) mice in the vaccinated and challenged group.
In a similar experiment, partial protection was observed
by Garcia et al. [21], who used T. gondii rhoptry proteins
and immunostimulating complexes (ISCOMS) as an adju-
vant to vaccinate pigs. Dubey et al. [25] tested a vaccine
incorporating a low dose of irradiated T. gondii oocysts,
and although fewer tissue cysts were observed in mice,
cysts were detected in 45/110 (40.9%) of mice which had
received porcine tissues from vaccinated pigs. In other
work by Dubey et al. [18] using tachyzoites of a non-
persistent strain of T. gondii (RH) to vaccinate pigs, only
partial protection was described, with fewer tissues cysts
in mice inoculated with porcine tissues. Similar results
were also reported using the T. gondii TS-4 mutant to vac-
cinate pigs [43,44], where the vaccine alone did not per-
sist, however only partial protection was observed
following challenge with GT-1 oocysts. In summary, apart
for the research described within this manuscript, none of
the literature currently available can describe 100% pro-
tection against tissue cyst formation in mice, following
bioassay of porcine tissues.
From the current results, it appears that vaccination
with S48 alone does not induce tissue cyst formation in
porcine tissues, as results from the mouse bioassay,
which included inocula with porcine tissues from the
vaccinated and challenged animals, were all PCR nega-
tive for T. gondii. If a positive had been obtained from
this group, the experiment had been designed to verify
whether infection was due to vaccination (S48) or oocyst
challenge (M4), as previously shown in lambs [11] (both
S48 and M4 are different T. gondii genotypes; S48 = type
I, M4 = type II). However, a bioassay using porcine tis-
sues from animals that were vaccinated alone (which
was not included in this study), could further support
this result.
The results also show that there were differences in sur-
vival rates within groups of mice which were inoculatedusing tissues from G1 pigs, depending on which type of
tissue they had been inoculated with (Figure 4). A greater
proportion of mice survived which had received porcine
inocula from the “food” tissue group (chop, loin, left tri-
ceps and left semitendinosus), compared with mice which
had received tissues from the “brain” and “other” tissue
groups (diaphragm, heart, tongue and masseter). This sug-
gests that there are a greater number of viable parasites
within tissues from the “brain” and “other” groups in com-
parison to tissues that are used routinely for human con-
sumption (“food”). To further confirm this result, T.
gondii DNA was detected in the brains of all mice which
were euthanised due to clinical signs of T. gondii infection,
with parasite DNA being detected in fewer bioassay mice
which had received porcine tissues from the “food” group
using tissues from G1 pigs (oocysts challenged pigs), com-
pared with mice which received brain or tissues from the
“other” group (Table 4).
In addition, two mice (C11-1 and C11-2), which had
been inoculated with tissues from G1 pigs that survived
until the end of the experiment (day 42) but also tested
positive for T. gondii by detection of parasite DNA in
their brains. Accordingly, they were the only two mice
which gave a seropositivity of greater than 3% with the
T. gondii IgG ELISA. It is likely that mice, which were
euthanised within the first 14 days of the bioassay, which
also tested positive for the presence of T. gondii DNA in
their brains, may only just have started to mount a
humoral immune response against the parasite, however,
the levels of IgG present were possibly too low to be de-
tected by the ELISA.
Although the T. gondii specific ITS1 PCR was carried
out using DNA from individual porcine tissues (brain,
chop, loin, left tricep, left semitendinosus, diaphragm,
heart, tongue and masseter), parasite DNA could not be
detected from any tissues. When comparing this result
with a similar study carried out in lambs [11], where T.
gondii DNA was detected from individual tissues by
ITS1 PCR, it is likely that the challenge dose of 1000 oo-
cysts may be too low to be detected by this method. Al-
though 1000 M4 oocysts is more likely to reflect that of
a natural infection, it appears that a higher challenge
dose (500 000 M4 oocysts as used by [11]), may result in
a greater chance of detecting parasite DNA directly from
the hosts tissue, without the need for mouse bioassay or
detection of parasite DNA from bioassay inocula. In
addition, direct detection of parasite DNA from porcine
tissues used only 1 g of starting material, compared with
50 g of tissue which was prepared for mouse bioassay,
therefore, due to the inhomogeneous distribution of
parasite tissue cysts there was less chance of detecting
the parasite from a smaller 1 g sample. In the current
study, detection of parasite DNA from bioassay inocula
was tested by two different molecular techniques; the
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determine which test was more sensitive and whether ei-
ther technique was as sensitive as mouse bioassay (the
“gold standard” assay for detection of viable tissue cysts).
Although detection of parasite DNA from mouse brains,
following bioassay by ITS1 PCR, detected the greatest
number of positive samples there was no evidence of a
difference between two molecular tests. However, the
sensitivity of the ITS1 PCR was slightly higher than the
529 bp qPCR (0.78 and 0.67 respectively). It should also
be noted that although these two molecular techniques
successfully detect parasite DNA, it is still currently only
the mouse bioassay which has the ability to detect viable
tissue cysts, and their potential to infect another host.
However, perhaps future methodology could employ
both molecular detection of the parasite from bioassay
inocula in conjunction with mouse bioassay, with a
view to reducing the number of mice used within the
bioassay, such as magnetic capture qPCR (MC-qPCR)
of T. gondii DNA as described by [10]. Histological
examination of porcine samples was of limited use to
detect the parasite in the porcine tissue or to show dif-
ferences between the groups of infected mice. How-
ever, it showed how vaccination protected against the
occurrence of lesions in the brain (perivascular foci)
after infection. Immmunohistochemical labelling was
also ineffective when trying to localize the parasite, as
only in two animals tachyzoites-like structures were
detected. These results from pathological studies sug-
gest that these techniques are not adequate when
studying parasite distribution in studies where no (por-
cine experiment) or very similar (murine bioassay) le-
sions are originated.
Overall, in terms of vaccination to reduce viable tis-
sue cysts in meat, these results are promising, as this
is the first description of 100% protection against tis-
sue cyst formation in mice following mouse bioassay
of tissues from pigs. The results also provide an an-
swer to the question raised by the Food Standards
Agency, in a recent report published by the Advisory
Committee on the Microbiological Safety of Food
(ACMSF), the document states that one of the know-
ledge gaps relevant to a risk assessment in the UK is:
“vaccines based on live attenuated strains of tachy-
zoites are effective in reducing morbidity in sheep but
it is not known whether vaccination has any effect on
the formation of tissue cysts” [26]. From the current re-
search it is now clear that S48 does have a significant
effect in reducing the formation of tissue cysts in pigs.
Vaccination of other “high risk” livestock species
should be addressed and it has recently been demon-
strated that vaccination of sheep with S48 also results
in a reduction in the number of ovine tissue samples
in which parasite DNA can be detected [11].Competing interests
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